Association between immune-related adverse event timing and treatment outcomes

The timing of immune-related adverse events (irAE) associated with immune checkpoint inhibitors (ICI) is highly variable. Although the development of irAE has been associated with ICI clinical benefit, how irAE timing influences this association is unknown. We analyzed two independent cohorts includ...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsiehchen, David, Naqash, Abdul Rafeh, Espinoza, Magdalena, Von Itzstein, Mitchell S., Cortellini, Alessio, Ricciuti, Biagio, Owen, Dwight H., Laharwal, Mehak, Toi, Yukihiro, Burke, Michael, Xie, Yang, Gerber, David E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741287/
https://www.ncbi.nlm.nih.gov/pubmed/35003896
http://dx.doi.org/10.1080/2162402X.2021.2017162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741287/
https://www.ncbi.nlm.nih.gov/pubmed/35003896
http://dx.doi.org/10.1080/2162402X.2021.2017162

Ejemplares similares